Senator Collins Announces Nearly $700,000 for Front Street Shipyard in Belfast

Washington, D.C. – U.S. Senator Susan Collins (R-ME), the Chairman of the Transportation Appropriations Subcommittee, announced today that Front Street Shipyard in Belfast has been awarded $667,028 through the Department of Transportation’s Maritime Administration’s (MARAD) Small Shipyard Grant Program.  This funding will assist Front Street Shipyard in purchasing and installing a new waterjet cutting machine on its premises to construct modern, lightweight carbon fiber ferries.

 

Read More...

Senator Collins’ Statement on Administration Examining Drug Importation to Lower Prescription Drug Prices

Washington, D.C. - U.S. Senator Susan Collins issued this statement following today’s announcement by the Administration that it is exploring how to safely import prescription drugs from other countries in the event of a dramatic price increase for a drug produced by one manufacturer and not protected by a patent.  Department of Health and Human Services Secretary Alex Azar asked Food and Drug Administration Commissioner Scott Gottlieb to establish a working group on this topic.

Read More...

Senators Collins, Jones Introduce Bill to Prevent American Taxpayers and Seniors from Falling Victim to Identity Theft

Washington, D.C. - In order to help combat identity theft and protect hardworking Americans from being robbed of their tax refunds through fraud, U.S. Senators Susan Collins (R-ME) and Doug Jones (D-AL) introduced the Taxpayer Identity Protection Act, legislation requiring the IRS to expand its Identity Protection PIN (IP PIN) pilot program nationwide over the next five years. 

 

Read More...

Senators Collins, King Announce Jackson Laboratory to Receive $4.1 Million Over Five Years to Research Alzheimer’s Disease

WASHINGTON, D.C. – Today, U.S. Senators Susan Collins (R-Maine), the founder and co-chair of the Congressional Task Force on Alzheimer’s disease, and Angus King (I-Maine) announced that The Jackson Laboratory in Bar Harbor has been awarded $873,647 for the year to study the progression and genetic causes of Alzheimer’s. The award is a part of a five-year allocation that will ultimately amount to $4,191,258 by 2023. The funds were awarded by the U.S. Department of Health and Human Services’ (DHHS) National Institute on Aging.

 

Read More...

Pages